Literature DB >> 19407115

Novel dhps and pfcrt polymorphisms in Plasmodium falciparum detected by heteroduplex tracking assay.

Jonathan J Juliano1, David J Bacon, Jianbing Mu, Xinhua Wang, Steven R Meshnick.   

Abstract

Several single nucleotide polymorphisms (SNPs) have been linked to antimalarial drug resistance in Plasmodium falciparum. However, standard polymerase chain reaction (PCR) methods to detect these polymorphisms are unable to detect SNPs in variants representing < 20% of the parasites in a mixed infection, nor can they detect polymorphisms at nearby loci. Here we use heteroduplex tracking assays (HTAs) to analyze dhps540 mutations in 96 samples from Peru and pfcrt76 mutations in 70 samples from China. All samples had been previously analyzed by standard PCR. We detected drug-resistant minority variants and two novel non-synonymous pfcrt mutations in China. In Peru, we found no drug-resistant minority variants and a synonymous mutation in dhps. Thus, even in regions of low malaria transmission, HTA assays are more informative than PCR with agarose gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407115      PMCID: PMC2755572     

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Estimating true antimalarial efficacy by heteroduplex tracking assay in patients with complex Plasmodium falciparum infections.

Authors:  Jesse J Kwiek; Alisa P Alker; Emily C Wenink; Marjorie Chaponda; Linda V Kalilani; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  Measuring allelic heterogeneity in Plasmodium falciparum by a heteroduplex tracking assay.

Authors:  Warunee Ngrenngarmlert; Jesse J Kwiek; Deborah D Kamwendo; Kimberly Ritola; Ronald Swanstrom; Chansuda Wongsrichanalai; R Scott Miller; Wanida Ittarat; Steven R Meshnick
Journal:  Am J Trop Med Hyg       Date:  2005-06       Impact factor: 2.345

3.  Minority-variant pfcrt K76T mutations and chloroquine resistance, Malawi.

Authors:  Jonathan J Juliano; Jesse J Kwiek; Kathryn Cappell; Victor Mwapasa; Steven R Meshnick
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

4.  Decreased prevalence of the Plasmodium falciparum chloroquine resistance transporter 76T marker associated with cessation of chloroquine use against P. falciparum malaria in Hainan, People's Republic of China.

Authors:  Xinhua Wang; Jianbing Mu; Guoqiao Li; Peiquan Chen; Xingbo Guo; Linchun Fu; Lin Chen; Xinzhuan Su; Thomas E Wellems
Journal:  Am J Trop Med Hyg       Date:  2005-04       Impact factor: 2.345

5.  Rapid real-time PCR genotyping of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum.

Authors:  Alisa P Alker; Victor Mwapasa; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

6.  Effects of Plasmodium falciparum mixed infections on in vitro antimalarial drug tests and genotyping.

Authors:  Shengfa Liu; Jianbing Mu; Hongying Jiang; Xin-zhuan Su
Journal:  Am J Trop Med Hyg       Date:  2008-08       Impact factor: 2.345

7.  Detection of the dihydrofolate reductase-164L mutation in Plasmodium falciparum infections from Malawi by heteroduplex tracking assay.

Authors:  Jonathan J Juliano; Paul Trottman; Victor Mwapasa; Steven R Meshnick
Journal:  Am J Trop Med Hyg       Date:  2008-06       Impact factor: 2.345

8.  World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.

Authors:  Christopher V Plowe; Cally Roper; John W Barnwell; Christian T Happi; Hema H Joshi; Wilfred Mbacham; Steven R Meshnick; Kefas Mugittu; Inbarani Naidoo; Ric N Price; Robert W Shafer; Carol H Sibley; Colin J Sutherland; Peter A Zimmerman; Philip J Rosenthal
Journal:  Malar J       Date:  2007-09-06       Impact factor: 2.979

  8 in total
  2 in total

1.  Relevance of undetectably rare resistant malaria parasites in treatment failure: experimental evidence from Plasmodium chabaudi.

Authors:  Silvie Huijben; Brian H K Chan; Andrew F Read
Journal:  Am J Trop Med Hyg       Date:  2015-05-04       Impact factor: 2.345

2.  The perils of PCR: can we accurately 'correct' antimalarial trials?

Authors:  Jonathan J Juliano; Nahla Gadalla; Colin J Sutherland; Steven R Meshnick
Journal:  Trends Parasitol       Date:  2010-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.